Insights

Could this ASX 200 healthcare share be set to recover in 2021?

Could the Ramsay Health Care Ltd (ASX: RHC) share price make a comeback in 2021? Here’s what big brokers have to say.
The post Could this ASX 200 healthcare share be set to recover in 2021? appeared first on Motley Fool Australia. –

healthcare, hospital, operating theatre, operating room, health, doctor

The Ramsay Health Care Limited (ASX: RHC) share price has largely been flat since 2015. The company had previously delivered Afterpay Ltd (ASX: APT) like returns for many years before its plateau. 

With the company’s first quarter update pushing its share price 5% higher last Friday, could Ramsay be a turnaround story in 2021? Here’s what big brokers had to say. 

First quarter FY21 recap 

Ramsay Australia reported a 1.5% increase in total revenue, or a 6.6% increase excluding Victoria. This reflects a 1.7% increase in surgical admissions (ex-Victoria up 8%) and lower non-surgical activity. The Australian business experienced a decline in earnings before interest, tax, depreciation, amortisation (and restructuring or rent costs) (EBITDAR) compared to the prior corresponding period. This was impacted by the coronavirus restrictions on activity in Victoria’s second lockdown and the increased costs. 

The company’s European division reported a 5.4% increase in surgical volumes combined with lower non-surgical activity. A similar narrative to the Australian business. 

Ramsay UK reported a 9.9% decline in total revenue with volumes picking up in the latter part of the quarter. The United Kingdom and France currently operate under government support arrangements which both run until 31 December 2020. 

The company was unable to provide a guidance for FY21 given the near-term uncertainties in the market. Notwithstanding the current environment, it believes that over the medium to long term, the healthcare industry fundamentals remain positive.

The Ramsay share price rallied 5% on the day of its first quarter announcement but remains near its post-COVID highs, just shy of $70.  

Broker updates 

Citi raised its Ramsay share price target from $70 to $71. It upgraded expected earnings for Australian operations but anticipates that Europe will likely take longer to return to normal. Overall expected earnings for FY22 and FY23 were upgraded by 2% each. 

Credit Suisse lowered its Ramsay share price target from $70 to $69 and retains a neutral rating. The broker is not impressed with the first quarterly trading update but notes the improvement in Australian operations. Overseas earnings are still at risk and costs are rising. 

Macquarie Group Ltd (ASX: MQG) raised its Ramsay share price target from $73.15 to $73.65 and retains an outperform rating. The broker sees the positives in the first quarter trading update, particularly in Australian activity levels. It notes rising costs due to the pandemic, but still sees longer term growth and value

Free Stock Report: 5 stocks under $5

We hear it over and over from investors, “I wish I had bought Altium or Afterpay when they were first recommended by The Motley Fool. I’d be sitting on a gold mine!” And it’s true.

And while Altium and Afterpay have had a good run, we think these 5 other stocks are screaming buys. And you can find out the names of these stocks in the FREE stock report.

Click here for your FREE stock report

*Extreme Opportunities returns as of November 14th 2020

More reading

Motley Fool contributor Lina Lim has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Could this ASX 200 healthcare share be set to recover in 2021? appeared first on Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!